Certain expression patterns associated with lower OS rates, advanced tumor stages and the presence of TP53 mutations, as described above, lead us to recommend that low IL-37 expression is associated with more advanced BLCA cases of poorer prognosis. Here, TP53 is linked to bladder transitional cell carcinoma.